Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems

IgA Nephropathy

  • - General Urology - Common Urological Problems - Medical Renal Disease
  • Jul 29, 2010
  • Comments
  • Viewed: 9049
  
Tags: | berger's disease | glomerulopathy | hematuria | hypertension |

Primary   hematuria   (idiopathic   benign   and   recurrent hematuria,  Berger’s disease)  is now known to be an immune complex glomerulopathy in which deposition of IgA occurs in a granular pattern in the mesangium of the glomerulus.  The associated light microscope findings are variable and range from normal to extensive crescentic glomerulonephritis.

Recurrent macroscopic and microscopic hematuria and mild proteinuria are usually the only manifestations of renal disease. Most patients with IgA nephropathy are between the ages of 16 and 35 years at the time of diagnosis. The disease occurs much more frequently in males than females and is the most common cause of glomerulonephritis in Asians.  While most patients continue to have episodes of gross hematuria or microscopic hematuria, the renal function is likely to remain stable. However, approximately 30% of patients will have progressive renal dysfunction and develop end-stage renal disease.

Clinical features that indicate a poor prognosis include male sex,  older age at onset of disease,  the presence of nephrotic-range proteinuria, hypertension, or renal dysfunction at presentation.

There is no satisfactory therapy for IgA nephropathy.

Diagnosis of Medical Renal Disease

Medical Renal Disease

The role of immunosuppressive drugs such as steroids and cytotoxic agents is not clear, and there have been few rigorously performed controlled trials.  A more intriguing approach is the use of omega-3 fatty acids (fish oils)  to delay progression of the renal disease. A large prospective randomized placebo-controlled trial in patients with IgA nephropathy using 12 g of omega-3 fatty acids has shown that fish oils probably can reduce the deterioration of renal function and the number of patients in whom end-stage renal disease develops.


***
Flavio G. Vincenti, MD, & William J.C. Amend, Jr., MD

***
REFERENCES

  1. Adler S: Diabetic nephropathy: Linking histology, cell biology, and genetics. Kidney Int 2004;66:2095.
  2. Alric L et al: Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN. Am J Kidney Dis 2004;43:617.
  3. Appel GB et al: Membranoproliferative glomerulonephritis Type II (dense deposit disease): An update. J Amer Soc Neph 2005;16: 1392.
  4. Barratt J, Feehally J: IgA nephropathy. J Amer Soc Neph 2005;16: 2088.
  5. Braden GL et al: Tubulointerstitial diseases. Am J Kidney Dis 2005; 46:560.
  6. Buhaescu I et al: Systemic vasculitis: Still a challenging disease. Am J Kidney Dis 2005;46:173.
  7. Chesney R: The changing face of childhood nephrotic syndrome. Kidney Int 2004;66:1294.
  8. Flanc RS et al: Treatment of diffuse proliferative lupus nephritis: A meta-analysis of randomized controlled trials. Am J Kidney Dis 2004;43:197.
  9. Couser WG (guest editor): Frontiers in nephrology: Membranous nephropathy. J Amer Soc Neph 2005;16:1184.
  10. Ginzler EM et al: Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N Engl J Med 2005;353:2219.
  11. Grantham JJ: Advancement in the understanding of polycystic kidney disease: A system approach. Kidney Int 2003;64: 1154.
  12. Heering P et al: Cyclosporine A and chlorambucil in the treatment of idiopathic focal segmental glomerulosclerosis. Am J Kidney Dis 2004;43:10.
  13. Hruska KA: Treatment of chronic tubulointerstitial disease: A new concept. Kidney Int 2002;61:1911.
  14. Imaging the Kidney-Radiologic Imaging 2006. (Excerpts) Nephron Clin Pract 2006;103:c19.
  15. Izzedine H et al: Oculorenal manifestations in systemic autoimmune diseases. Am J Kidney Dis 2004;43:209.
  16. Javaid B, Quigg RJ: Treatment of glomerulonephritis: Will we ever have options other than steroids and cytotoxics? Kidney Int 2005;67:1692.
  17. Nair R, Walker PD: Is IgA nephropathy the commonest primary glomerulopathy among young adults in the USA? Kidney Int 2006;69:1455.
  18. Noris M, Remuzzi G: Hemolytic uremic syndrome. J Amer Soc Neph 2005;16:1035.
  19. Perna A et al: Immunosuppressive treatment for idiopathic membranous nephropathy: A systematic review. Am J Kidney Disease 2004;44:385.
  20. Rosner MH, Bolton WK: Renal function testing. Am J Kidney Dis 2006;47:174.
  21. Rossert J: Drug-induced acute interstitial nephritis. Kidney Int 2001; 60:804.
  22. Tenenhouse HS, Murer H: Disorders of renal tubular phosphate transport. J Am Soc Neph 2003;14:240.
  23. Troyanov S et al: Renal pathology in idiopathic membranous nephropathy: A new perspective. Kidney Int 2006;69:1641.
  24. Wilmer WA et al: Management of glomerular proteinuria: A commentary. J Amer Soc Neph 2003;14:3217.

Bookmark and Share

Post a comment [ + Comment here + ]

There are no comments for this entry yet. [ + Comment here + ]




Comment
Your details

* Required field


Please enter the word you see in the image below:

Comments are moderated by our editors, so there may be a delay between submission and publication of your comment. Offensive or abusive comments will not be published.

secondary tumor1 - hot flashes2 - catheters1 - genitourinary tract2 - urethrotomy1 - vur1 - pelvic circulation1 - diagnostic testing1 - section of nephrology1 - dissolution agents1 - estradiol deficiency1 - x-ray1 - vascular diseases1 - routine antenatal sonography1 - bone metastases3 - journal of the national cancer institute1 - excess potassium secretion1 - sphincter deficiency4 - premenopausal women2 - dana-farber cancer institute1 - ungal1 - embryonic urothelium1 - heart palpitations1 - perineal membrane1 - kidney masses1 - melamine-induced kidney disease1 - levator hiatus1 - urethral valve1 - hyperglycemia1 - urethral diverticulum1 -